Board of directors
Pursuant to article 20 of the company's by-laws and article 7 of the Regulations of the Board of Directors, the Board of Directors will be responsible for the company‘s management and legal representation and will be composed by a minimum of three and a maximum of fifteen members.
Currently, the Board of Directors is formed by 13 members. The current Board members are the following:
| Name || Position || Type ||First appointment||Last appointment|
|Víctor Grífols Roura|| Chairman |
|Raimon Grífols Roura||Co-CEO||Executive||29/05/15||--|
|Víctor Grífols Deu||Co-CEO||Executive||27/05/16||--|
|Ramón Riera Roca||Director||Executive||13/04/00(3)||26/05/17|
|Tomás Dagá Gelabert||Director and Vice Secretary|| Other |
|Thomas Glanzmann|| Vice Chairman |
| Other |
|Anna Veiga Lluch||Director||Independent||09/12/08||29/05/15|
|Steven F. Mayer||Director||Independent||25/01/11||27/05/16|
| Luis Isasi Fernández de Bobadilla ||Director||Independent||24/05/11||27/05/16|
|Belén Villalonga Morenés||Director||Independent||24/05/13||--|
|Iñigo Sánchez- Asiaín Mardones||Lead independent||Independent||29/05/15||--|
|Carina Szpilka Lázaro||Director||Independent||29/05/15||--|
|Nuria Martín Barnés|| Secretary |
(1) Between 08/07/91 and 30/05/02, the position of director was held by Deria, S.A., which was represented by Víctor Grifols Roura.
(2) Between 25/05/01 and 30/05/02, the position of director was occupied by Grifols Engineering, S.A., which was represented by Juan Ignacio Twose Roura.
(3) Between 25/05/01 and 30/05/02, the position of director was held by Grifols International, S.A., which was represented by Ramón Riera Roca.
Biographies of the members of the board:
Mr. Víctor Grífols Roura is non-executive Chairman and proprietary director since 1 January 2017. Prior to this date and since 1985 he held the role of Chief Executive Officer and top executive of the Grifols Group, succeeding his father Mr. Victor Grífols Lucas at the performance of said tasks, spearheading the 1987 reorganization that created Grifols as it is today. Mr. Grífols Roura originally joined the Group in 1973 as an Export Manager and later served as Sales Manager. Since 2014 he is member of the Board of Directors of Criteria Caixa, S.A., Sociedad Unipersonal. Mr. Grífols Roura earned a business administration degree from the University of Barcelona.
Relation with significant shareholders: Victor Grífols Roura is a shareholder of Deria S.A. (a non-controlling shareholder, pursuant the Spanish Securities Market Act). He is also a shareholder of Scranton Enterprise, B.V. (a non-controlling shareholder, pursuant to the Spanish Securities Market Act). Nuria Roura Carreras (Rodellar Amsterdam Holdings B.V.) is the mother of Victor Grífols Roura Back to top
Mr. Raimon Grífols Roura is Grifols' joint and several Chief Executive Officer together with Victor Grífols Deu since 1 January 2017. He succeeds his brother Victor Grífols Roura on the position. He is a member of the administration bodies of several companies within the Grifols Group. From 2001 to 2015 he held the role of non-member secretary of the Board of Directors of Grifols, S.A., serving as Director and Vice-Secretary of the Board of Directors since 2015. In May 2016 the Board accepted his resignation as vice secretary. Until his appointment as executive director in July 2016 Mr. Grífols Roura was a partner at the law firm Osborne Clarke in Spain. Currently he is a Sole Director of Deria, S.A. Mr. Grífols earned his degree in law from the University of Barcelona (Universidad de Barcelona).
Relation with significant shareholders: Raimon Grífols Roura is sole administrator and a shareholder of Deria S.A. (a non-controlling shareholder, pursuant to the Spanish Securities Market Act). He is also a shareholder of Scranton Enterprise, B.V. (a non-controlling shareholder, pursuant to the Spanish Securities Market Act). Nuria Roura Carreras (Rodellar Amsterdam Holdings B.V.) is the mother of Raimon Grífols Roura. Back to top
Mr. Víctor Grífols Deu is Grifols' joint and several Chief Executive Officer together with Raimon Grífols Roura since 1 January 2017. He succeeds his father Victor Grífols Roura on the position. He is a member of the administration bodies of several companies within the Grifols Group and was appointed executive director in May 2016. He joined the Company in 2001 as an analyst in the Planning and Control Department of the Company. In 2008 he became the director of the Planning and Control Department and was also appointed member of the Executive Committees. He has been part of the team that analysed and was responsible for the integration of the operations after the acquisition of Alpha Therapeutics, Talecris Biotherapeutics and Novartis' Transfusion Diagnostic Unit. He graduated in Business Administration and Management from the Ramon Llull University – Sarrià Chemical Institute and holds a postgraduate degree in Business Administration and Management from Michael Smurfit Business School in Dublin.
Relation with significant shareholders: Víctor Grífols Deu is the grandson of Nuria Roura Carreras (Rodellar Amsterdam Holdings B.V.). Back to top
Ramón Riera Roca
Mr. Ramón Riera Roca joined Grifols in 1977 and serves as Chief Operations Officer as well as being a member of the administration bodies of several companies of the Grifols Group. Mr. Riera earned a degree in Chemical Sciences from the Autonomous University of Barcelona.
Relation with significant shareholders: Ramón Riera Roca is a shareholder of Scranton Enterprise, B.V. (a non-controlling shareholder, pursuant to the Spanish Securities Market Act). Back to top
Tomás Dagá Gelabert
Mr. Tomás Dagá Gelabert has served as director of Grifols, S.A. since April 2000 and also as vice secretary of the board since May 2016. He is the managing partner and founder of the law firm Osborne Clarke in Spain. Prior to joining Osborne Clarke, he worked in the corporate and tax department of Peat Marwick Mitchell & Co. in Barcelona. He is currently a member of the Board of Directors of Kiro Robotics S.L., Biomat USA, Inc., Talecris Plasma Resources, Inc., Grifols Diagnostic Solutions Inc. and Grifols Worldwide Operations Limited. He is also a trustee and the Secretary of the private foundation Víctor Grífols i Lucas, a trustee of the Probitas Fundación Privada foundation and the Secretary non-board member of the Board of Directors of Progenika Biopharma, S.A. and Araclon Biotech, S.L. Mr Dagá earned his degree in Law from the University of Barcelona (Universidad de Barcelona).
Relation with significant shareholders: Tomás Dagá Gelabert is a shareholder of Scranton Enterprise, B.V. (a non-controlling shareholder, pursuant of the Spanish Securities Market Act). Back to top
Thomas H. Glanzmann
Mr. Thomas H. Glanzmann has served as a director of Grifols, S.A. since April 2006 and on 1 January 2017 he was appointed non-executive Vice President of the Board of Directors. He also serves as a Director on the Boards of Sulzer AG, Sage products Inc and is a Healthcare Advisor to Madison Dearborn and Partners. From 2006 until 2011 he was the Chief Executive Officer and President of Gambro AB. Prior to this Mr. Glanzmann was the CEO and Managing Director of HemoCue AB. Between 1988 and 2004 he held various positions at Baxter Healthcare: Senior Vice President and Corporate Officer of Baxter Healthcare Corporation; President of Baxter Bioscience; Chief Executive Officer of Immuno International; and President of the European Biotech Group. Between 1984 and 1988 he worked at Philip Morris where he amongst other was the country manager for Norway, Denmark and Iceland. He also was a Senior Advisor to the Executive Chairman and a Managing Director at The World Economic Forum in Davos from 2004 - 2005 and the Chairman of the Plasma Protein Therapeutics Association (PPTA) between 2000 and 2001. Mr. Glanzmann holds a M.B.A. from IMD in Switzerland, a B.A. in Political Science from Dartmouth College, USA. and a Board of Directors Certification from the UCLA Anderson School of Management, USA. Back to top
Anna Veiga Lluch
Ms. Anna Veiga Lluch graduated in Biology and received a Ph.D in Biology (Cum Laude) from the Universidad Autónoma de Barcelona. She has been the IVF laboratory Director at the Reproductive Medicine Service at Institut Universitari Dexeus from 1982 to 2005. She is the Director of the Stem Cell Bank at the Centre for Regenerative Medicine in Barcelona, Scientific Director at the Reproductive Medicine Service of the Institut Universitari Dexeus, and an Associate Professor at the Department of Experimental and Health Sciences of the Universitat Pompeu Fabra in Barcelona. She is also a member of the Board of Trustees of the Fundación Dexeus de la Salud de la Mujer and an Honorific Member of the Institut Medicofarmacèutic de Catalunya. In May 2015 she received the degree as Doctor Honoris Causa from the Universitat Central de Catalunya. She specializes in clinical embryology, reproductive genetics, embryonic and pluripotent stem cells research and bioethics. Back to top
Steven F. Mayer
Mr. Steven F. Mayer is Senior Managing Director, Co-Head of Global Private Equity, and Chairman of the Investment Committee of Cerberus Capital Management, L.P. Mr. Mayer is the managing director of Cerberus California, LLC and predecessor entities since November 2002. Likewise, Mr. Mayer is a member of the boards of directors of BlueLinx Holdings, Inc., Starrus Holdings Limited, TransCentra Inc. and YP Holdings LLC. Mr. Mayer received his AB, cum laude, from Princeton University and his JD, magna cum laude, from Harvard Law School. Back to top
Luis Isasi Fernández de Bobadilla
Mr. Luis Isasi Fernández de Bobadilla is Managing Director of Morgan Stanley in Spain and Country Head for the Iberia region. He joined Morgan Stanley in London in 1987. Prior to that, he served as executive director at First Chicago Ltd. in London and, previously, worked in New York for the Latin American department of Morgan Guaranty Trust Co. Mr. Isasi started his professional career in Abengoa, in Seville (Spain) in 1977. Mr. Isasi has a Bachelor's Degree in Business by the University of Seville, and holds a M.B.A. from Columbia Business School in New York, United States, obtained in 1982. Back to top
Belén Villalonga Morenés
Ms. Belén Villalonga Morenés is an Associate Professor with Tenure at New York University's Stern School of Business. Between 2001 and 2012 she was a faculty member at Harvard Business School. She serves as an independent director at Acciona, leader in the renewable energy and infrastructure businesses, since 2006, and at Talgo, a high-speed train manufacturer, since 2015. She is also a Senior Associate Partner at Cambridge Advisors to Family Enterprise, a family business consulting company. Her teaching, research, and consulting activities are in the areas of corporate strategy, finance, and governance, with a special focus on family-controlled companies. Her award-winning research, which has been published in the top academic journals, has been cited extensively in academic articles and in the international media. She holds a Ph.D. in Management and an M.A. in Economics from the University of California at Los Angeles, where she was a Fulbright Scholar. She also holds a second Ph.D. in Business Economics from the Complutense University of Madrid and a B.A. in Economic and Management Sciences from the Colegio Universitario de Estudios Financieros in Madrid. Before starting her doctoral studies, she worked at McKinsey & Co. in Paris. Back to top
Marla E. Salmon
Ms. Marla E. Salmon is Professor of Nursing and Public Health at the University of Washington, as well as Senior Visiting Fellow of Public Affairs. Her career has focused on health policy and capacity building in both global and US contexts, working with governments, international agencies and other health –related entities. Her most recent work focuses on social enterprise and development in the health sector. Salmon holds a doctorate in health policy and administration from the Johns Hopkins University, degrees in political science and nursing from the University of Portland, and was a Fulbright Scholar at the University of Cologne (Germany).She holds two honorary doctoral degrees recognizing her national and international service and is a member of the Institute of Medicine. Her board service includes IES Abroad, Inc. the Robert Wood Johnson Foundation, and the National Center for Healthcare Leadership. Her advisory roles include the White House Task Force on Health Care Reform, the World Bank, the World Health Organization's Global Advisory Group on Nursing and Midwifery, and the National Institutes of Health National Advisory Committee for the Institute of Nursing Research. Back to top
Iñigo Sánchez- Asiaín Mardones
Mr. Iñigo Sánchez-Asiaín Mardones is the Lead Independent director of the Board since May 2015. He earned a degree in Business Administration from the Universidad Pontificia de Comillas in Madrid (ICADE) and an MBA from Harvard Business School. Since 2010 he is founding partner at Portobello Capital, a private equity company recognized this year as "Best Independent Investment Firm" in Spain by AI Magazine. He is member of the Executive Committee and Investment Committee at Portobello Capital, leading the investments in companies such as Angulas Aguinaga or Multiasistencia, companies in which he is Chairman and member of the Executive Committee. Previously he was Deputy General Director (Subdirector General) at Banco Santander (1993-2005) and was partner and member of the Board of Directors of Ibersuizas Gestión SGECR, S.A. (2005-2010). He is also Chairman of the Executive Committee at the Harvard Club of Spain. Back to top
Carina Szpilka Lázaro
Ms. Carina Szpilka Lázaro earned a degree in Business Administration from the Universidad Pontificia de Comillas in Madrid (ICADE) and an Executive MBA from the Instituto de Empresa. She began her professional career in the financial sector working at Banco Santander and Argentaria (now part of BBVA). In 1998 she was part of the team that founded ING Direct in Spain, where she occupied the position of CEO from 2010 to 2013, having previously occupied the same position in ING Direct France from 2008 to 2010. She is currently an independent director at Abanca and at Meliá Hotels International, as well as a partner at KFund Venture Capital and a member of the Advisory Board of Reparalia and of Oracle España. Since the beginning of 2014 she has been vice-president of UNICEF in Spain. She is also a member of the Professional Board of ESADE. In 2011 she was given the "Female Executive of the Year" award by the Spanish Federation of Female Directors, Executives, Professionals and Entrepreneurs (Federación Española de Mujeres Directivas - FEDEPE). Back to top
Nuria Martín Barnés
Ms. Núria Martín Barnés has served as Vice-Secretary non-member of the Board of Directors from 2001 to 2015, serving as Secretary non-member of the Board of Directors since 2015. Ms. Martín is a Partner at Osborne Clarke Spain. Prior to joining Osborne Clarke she worked in the Corporate and Tax Department of KPMG Peat Marwick from 1982 to 1986. Ms.Martín is also secretary and member of the Board of Directors of Compañía General de Inversiones, S.A., S.I.C.A.V., Gesiuris Asset Management, S.G.I.I.C., S.A., CAT Patrimonis, S.I.C.A.V., S.A., URC Patrimonis, S.I.C.A.V., S.A. and Technetix Spain, S.L.. Ms. Martín earned her law degree from the University of Barcelona. Back to top